# A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

> **NCT04083716** · PHASE1 · COMPLETED · sponsor: **Assembly Biosciences** · enrollment: 15 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** ABI-H2158 Reference Formulation
- **DRUG:** ABI-H2158 Test Formulation

## Key facts

- **NCT ID:** NCT04083716
- **Lead sponsor:** Assembly Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-06
- **Primary completion:** 2019-10-05
- **Final completion:** 2019-10-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04083716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04083716, "A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04083716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*